lactobacillus salivarius HN6

Lactobacillus salivarius HN6 is a specific strain of the probiotic bacterium L. salivarius that was originally isolated from the breast milk of a healthy woman. It is being developed as a live biotherapeutic product. The mechanism of action is thought to involve the restoration of a healthy microbial balance (microbiome) and the inhibition of pathogenic bacteria, such as Staphylococcus and Streptococcus species, which can cause infections. This strain has been specifically studied in a clinical trial for the treatment of lactational mastitis, a painful inflammation of the breast tissue that can occur during breastfeeding.